Lexaria Bioscience LEXX
NASDAQ LEXX
$2.74 -0.08 (-2.84%)
As of: Oct 22, 2026 · 9:30 AM EDT

Lexaria Bioscience (LEXX) Other Non-Current Assets (2011 - 2012)

Updated

Lexaria Bioscience (LEXX) recorded Other Non-Current Assets of $139,891 in fiscal Q2 2012 (quarter ended Apr 30, 2012).

Analysis

Lexaria Bioscience (LEXX) Other Non-Current Assets (2011 - 2012) Analysis & Trends

At the end of FY2011 (ended Oct 31, 2011), Lexaria Bioscience reported Other Non-Current Assets of $304,890.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,149.64 Bn 1,118.23 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 626.55 Bn 545.08 Bn 17.26 Bn 14.27 Bn
3 AbbVie 498.79 Bn 471.91 Bn 12.70 Bn 10.73 Bn
4 Merck 371.66 Bn 326.04 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 299.96 Bn 263.95 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 263.22 Bn 236.91 Bn 12.86 Bn -
7 Amgen 237.03 Bn 192.43 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 191.20 Bn 165.40 Bn 6.22 Bn 4.75 Bn
9 Pfizer 170.83 Bn 117.47 Bn 10.94 Bn 9.94 Bn
10 Lexaria Bioscience 2.53 Mn -12.73 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2012 188,762.00
Oct 31, 2011 337,982.00
API Access

Lexaria Bioscience Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=LEXX&period=max&api_key=YOUR_API_KEY